Related references
Note: Only part of the references are listed.Requirement for YAP1 signaling in myxoid liposarcoma
Marcel Trautmann et al.
EMBO MOLECULAR MEDICINE (2019)
Emerging roles of Hippo signaling in inflammation and YAP-driven tumor immunity
Yuhang Zhou et al.
CANCER LETTERS (2018)
The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer
Tingting Lu et al.
CANCER LETTERS (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
The physiological role of Motin family and its dysregulation in tumorigenesis
Tingting Huang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD
Mengxue Yu et al.
CELL DEATH & DISEASE (2018)
miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
Wei Kang et al.
CELL DEATH & DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis
Y. Wang et al.
ONCOGENE (2017)
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer
Sofia M. E. Weiler et al.
GASTROENTEROLOGY (2017)
IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis
Yuhang Zhou et al.
MOLECULAR CANCER (2017)
TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis
Y. Zhou et al.
ONCOGENE (2017)
DNA-binding mechanism of the Hippo pathway transcription factor TEAD4
Z. Shi et al.
ONCOGENE (2017)
The large tumor suppressor family: friend or foe?
Wei Kang et al.
JOURNAL OF THORACIC DISEASE (2017)
Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer
Soon Auck Hong et al.
APMIS (2017)
Emerging role of Hippo pathway in gastric and other gastrointestinal cancers
Wei Kang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin
Christophe Couderc et al.
NEOPLASIA (2016)
The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis
Yuhang Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma
Wei Kang et al.
MOLECULAR CANCER (2015)
Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression
Y-L Hsu et al.
ONCOGENE (2015)
Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer
Byungho Lim et al.
CARCINOGENESIS (2014)
YAP activation is an early event and a potential therapeutic target in liver cancer development
Andrea Perra et al.
JOURNAL OF HEPATOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Cyr61/CTGF/Nov family proteins in gastric carcinogenesis
Tsu-Yao Cheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic lumen expansion
Sara Hultin et al.
NATURE COMMUNICATIONS (2014)
The p130 Isoform of Angiomotin Is Required for Yap-Mediated Hepatic Epithelial Cell Proliferation and Tumorigenesis
Chunling Yi et al.
SCIENCE SIGNALING (2013)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
Niantao Deng et al.
GUT (2012)
The Amotl2 Gene Inhibits Wnt/β-Catenin Signaling and Regulates Embryonic Development in Zebrafish
Zhiqiang Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis
Wei Kang et al.
CLINICAL CANCER RESEARCH (2011)
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Bin Zhao et al.
GENES & DEVELOPMENT (2011)
Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
Wenqi Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
Murugan Paramasivam et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination
Cheng-Gang Jiang et al.
MOLECULAR CANCER (2011)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Angiomotin-Like Protein 1 Controls Endothelial Polarity and Junction Stability During Sprouting Angiogenesis
Yujuan Zheng et al.
CIRCULATION RESEARCH (2009)
Angiomotin regulates endothelial cell migration during embryonic angiogenesis
Karin Aase et al.
GENES & DEVELOPMENT (2007)
Amotl2 is essential for cell movements in zebrafish embryo and regulates c-Src translocation
Huizhe Huang et al.
DEVELOPMENT (2007)
Helicobacter pylori infection and the development of gastric cancer.
N Uemura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
